VENTANA MMR RxDx Panel by Roche

Manufacturer Roche
The VENTANA MMR RxDx Panel is the first and only immunohistochemistry-based assay approved to identify endometrial carcinoma patients eligible for treatment with JEMPERLI (dostarlimab). 


VENTANA MMR RxDx Panel by Roche product image
VENTANA MMR RxDx Panel

The supplier does not provide quotations for this particular product through SelectScience. You can search for similar products in our product directory.



0 Scientists have reviewed this product


Write the First Review

No Reviews

Intended use 

VENTANA MMR RxDx Panel is a qualitative immunohistochemistry test intended for use in the assessment of mismatch repair (MMR) proteins (MLH1, PMS2, MSH2 and MSH6) in formalin-fixed, paraffin-embedded (FFPE) endometrial carcinoma tissue by light microscopy. The OptiView DAB IHC Detection Kit is used for MSH6, MSH2 and MLH1, and the OptiView DAB IHC Detection Kit with the OptiView Amplification Kit is used for PMS2 on a VENTANA BenchMark ULTRA instrument.

Product Overview

VENTANA MMR RxDx Panel by Roche product image

VENTANA MMR RxDx Panel

Manufacturer Roche

Be the first to review this product